Thomas Jefferson Opens New Familial Colorectal Cancer Registry
PHILADELPHIA-Thomas Jefferson University’s new Familial Colorectal Cancer Registry is collecting information and blood and tissue samples from families with a higher-than-normal risk of colon cancer, to aid researchers looking for genetic markers of the disease and to provide genetic counseling and genetic testing, if appropriate, to participants.
PHILADELPHIAThomas Jefferson Universitys new Familial Colorectal Cancer Registry is collecting information and blood and tissue samples from families with a higher-than-normal risk of colon cancer, to aid researchers looking for genetic markers of the disease and to provide genetic counseling and genetic testing, if appropriate, to participants.
To date, 35 members of 24 families have been enrolled. Operations director Deborah Rose said she expects to have hundreds of new registry members in the next year.
Typically, a patient is referred to the registry by a physician, family member, or self-referral. To participate, patients may have either a personal or family history of a particular type of inherited colorectal cancer, such as familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer.
Others who are eligible include those who have had colorectal cancer diagnosed before age 30 and patients with a first-degree relative diagnosed with colorectal cancer before age 50.
For more information about the registry and clinical genetic testing, patients and physicians may call 1-800-JEFF-NOW (1-800-533-3669).
Articles in this issue
over 27 years ago
Tobacco Companies Reach Settlement With Texas for $15.3 Billionover 27 years ago
Archives to Collect Info on Radiation Exposure Worldwideover 27 years ago
Few BRCA-1 Carriers Take Recommended Precautionsover 27 years ago
Lifelong Weight Control a Key to Breast Ca Preventionover 27 years ago
Eight-Year Prostate Brachytherapy Update Shows Good Resultsover 27 years ago
Patient Brochure on Breast Cancer Tumor Markersover 27 years ago
Gay Men’s Health Crisis Calls for HIV Reporting in New Yorkover 27 years ago
Single-Agent Taxanes in Advanced Breast Cancer: A Commentaryover 27 years ago
ODAC Declines to Vote on DepoCyt FDA Recommendationover 27 years ago
Photofrin Approved for Early-Stage Lung CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Related Articles
- Mitazalimab/Chemo Yields Promising Survival/Responses in Untreated PDAC
September 22nd 2025
- 3 Things You Should Know About Data Presented at ESMO GI
September 22nd 2025
- P53 Mutations May Reveal Viability of Different Pancreatic Cancer Therapies
September 20th 2025
- ELI-002 7P Elicits T Cell Responses in Mutant KRAS-Driven Tumors
September 18th 2025
- Idylla CDx MSI Test Earns FDA Approval in MSI-H Colorectal Cancer
September 16th 2025
- New Blood Test Algorithm Shows Sensitivity, Specificity in CRC Screening
September 6th 2025